文献速递肾小球疾病慢性肾脏病急性肾损伤

儿童IgA肾病免疫抑制治疗及足细胞病变特征的临床价值

Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features.
PubMed 文献 · Kidney Int Rep · 2018-03-29

本研究回顾82例儿童IgA肾病,分析激素等免疫抑制治疗的疗效及牛津分类和足细胞病变特征的预后价值。免疫抑制组eGFR和蛋白尿显著改善,足细胞病变特征可预测肾功能下降,而MEST-C评分未能证明其预后价值。

要点

  • 免疫抑制治疗(尤其激素)对肾小球炎症和增生患儿可能有益
  • 足细胞病变特征对儿童IgA肾病长期肾脏预后有强预测价值
  • 牛津分类MEST-C评分在儿童中预测长期肾脏预后不完全适用

核心结论

  • 免疫抑制治疗尤其激素对肾小球炎症和增生的儿童IgA肾病似乎有益。
  • 牛津分类不完全适用于预测儿童长期肾脏预后,而足细胞病变特征对肾脏预后有强预测价值。

研究设计与样本

  • 回顾性分析82例连续儿童原发性IgA肾病,平均年龄10.6岁,中位随访3.3年。
  • 21例(25.6%)表现为急性肾损伤,6例(7.3%)表现为肾病综合征。
  • 肾活检按牛津分类和足细胞病变特征评分,比较免疫抑制组与仅支持治疗组。

主要发现

  • 免疫抑制组eGFR从M0的89.9 [61.2-114.5]升至M6的110.5 [93.7-120] ml/min per 1.73 m2,P < 0.001。
  • 免疫抑制组蛋白尿从1.6 [1-4.3]降至0.3 [0.2-0.7] g/g,P < 0.001。
  • 支持治疗组eGFR和蛋白尿保持稳定。
  • 足细胞病变特征预测肾功能下降,单变量分析为-4.9 ± 14.9 ml/min per 1.73 m2,P = 0.0079,多变量分析亦显著。
  • 足细胞病变特征在单变量分析中预测联合事件(6个月时肾功能损害超过基线eGFR 10%或CKD 3期)。

临床怎么用

  • 对肾小球炎症和增生的儿童IgA肾病可考虑免疫抑制治疗尤其激素。
  • 评估足细胞病变特征有助于预测儿童IgA肾病肾脏预后。
  • 牛津分类MEST-C评分在儿童中预测长期预后需谨慎解读。

局限性

  • 两组基线临床数据不同,不可比较。
  • 回顾性设计,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There is a need for treatment guidelines and prognostic factor identification in children with primary IgA nephropathy. We analyzed the causative effect of steroids and the applicability of the Oxford classification. METHODS: A total of 82 consecutive children (mean 10.6 years; median follow-up 3.3 years) were reviewed; 21 patients (25.6%) presented with acute kidney injury, and 6 (7.3%) with nephrotic syndrome. Renal biopsies were scored for Oxford classification and podocytopathic features in 2 groups: a group treated with steroid therapy (some in association with cyclophosphamide) and supportive care (renin angiotensin system blockade) and a group treated by supportive care alone. RESULTS: The 2 groups were not comparable because baseline clinical data were different. Estimated glomerular filtration rate (eGFR) in immunosupressive group significantly improved between M0 (at onset) and M6 (6 months after treatment) from 89.9 [61.2-114.5] to 110.5 [93.7-120] ml/min per 1.73 m2, P < 0.001. Proteinuria also significantly decreased from (1.6 [1-4.3] to 0.3 [0.2-0.7] g/g, P < 0.001). In the supportive care group, eGFR and proteinuria remained stable. Podocytopathic features were predictive of renal function decline by univariable (-4.9 ± 14.9 ml/min per 1.73 m2, P = 0.0079) and multivariable analysis and of poor renal prognosis to a combined event (renal function impairment more than 10% of the eGFR baseline or chronic kidney disease stage 3 at 6 months) in univariable analysis. MEST-C score failed to prove its prognostic value. CONCLUSION: Immunosuppressive treatment, especially steroid therapy, seems beneficial in children with glomerular inflammation and proliferation. The Oxford classification does not appear to be entirely appropriate in predicting long-term renal prognosis for children, whereas the characteristics of podocytopathy are strongly predictive of renal prognosis.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Cambier A, Rabant M, Peuchmaur M, et al. Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features. Kidney Int Rep. 2018. PMID: 29988999. doi:10.1016/j.ekir.2018.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。